| Nov 29, 2012 |
Palang Chotsiri |
Time to event and drop-out model
|
technical
|
| Nov 23, 2012 |
Pascal Girard |
Different EBE estimation between original and enriched dataset with MDV=1
|
technical
|
| Nov 23, 2012 |
Joachim Grevel |
RE: Different EBE estimation between original and enriched dataset with MDV=1
|
technical
|
| Nov 23, 2012 |
Jean Lavigne |
RE: Different EBE estimation between original and enriched dataset with MDV=1
|
technical
|
| Nov 23, 2012 |
Leonid Gibiansky |
Re: Different EBE estimation between original and enriched dataset with MDV=1
|
technical
|
| Nov 23, 2012 |
Bill Denney |
Re: Different EBE estimation between original and enriched dataset with MDV=1
|
technical
|
| Nov 26, 2012 |
Robert Bauer |
RE: Different EBE estimation between original and enriched dataset with MDV=1
|
technical
|
| Nov 26, 2012 |
Herbert Struemper |
RE: Different EBE estimation between original and enriched dataset with MDV=1
|
technical
|
| Nov 26, 2012 |
Pascal Girard |
RE: Different EBE estimation between original and enriched dataset with MDV=1
|
technical
|
| Nov 26, 2012 |
Leonid Gibiansky |
Re: Different EBE estimation between original and enriched dataset with MDV=1
|
technical
|
| Nov 27, 2012 |
Pascal Girard |
Re: Different EBE estimation between original and enriched dataset with MDV=1
|
technical
|
| Nov 27, 2012 |
Leonid Gibiansky |
Re: Different EBE estimation between original and enriched dataset with MDV=1
|
technical
|
| Nov 26, 2012 |
Johannes H. Proost |
Re: job opening
|
job
|
| Nov 22, 2012 |
Toufigh Gordi |
Next Rosa Impact Webinar: Bench to Bedside Translation of Antibody Drug Conjugates Using a Multiscale Mechanistic PK/PD Model: A Case Study with SGN-35
|
event
|
| Nov 21, 2012 |
Ayyappa Chaturvedula |
M3 method with log transformed data
|
technical
|
| Nov 22, 2012 |
Mats Karlsson |
RE: M3 method with log transformed data
|
technical
|
| Nov 19, 2012 |
Simon Davis |
testing new email address
|
technical
|
| Nov 19, 2012 |
Simon Davis |
Installation of both NONMEM 7.2 and Phoenix WinNonLin 6.x
|
technical
|
| Nov 19, 2012 |
David Cadieu |
Director, Pharmacometrics
|
job
|
| Nov 17, 2012 |
NONMEM |
unusual SAEM crash
|
technical
|
| Nov 17, 2012 |
Eileen Brigid Lawson |
NONMEM system requirements--what do I need?
|
technical
|
| Nov 16, 2012 |
Eileen Brigid Lawson |
NONMEM system requirements--what do I need?
|
technical
|
| Nov 15, 2012 |
R.Bruggemann |
installation of both NONMEM 7.2 and Phoenix WinNonLin 6.2
|
technical
|
| Nov 15, 2012 |
William Bachman |
RE: installation of both NONMEM 7.2 and Phoenix WinNonLin 6.2
|
technical
|
| Nov 15, 2012 |
Kevin Dykstra |
RE: installation of both NONMEM 7.2 and Phoenix WinNonLin 6.2
|
technical
|
| Nov 15, 2012 |
Robert Bauer |
RE: installation of both NONMEM 7.2 and Phoenix WinNonLin 6.2
|
technical
|
| Nov 15, 2012 |
Bernard Murray |
RE: installation of both NONMEM 7.2 and Phoenix WinNonLin 6.2
|
technical
|
| Nov 15, 2012 |
Kevin Dykstra |
popPK Reporting Survey
|
technical
|
| Nov 13, 2012 |
Jeffrey Barrett |
First Announcement - 2013 Sheiner Rowland Advanced PK/PD Course
|
event
|
| Nov 09, 2012 |
Laurent . Nguyen |
Open Position PK/PD Scientist - Fixed-term contract
|
job
|
| Nov 09, 2012 |
Paolo Denti |
PhD position in pharmacometrics - University of Cape Town
|
job
|
| Nov 07, 2012 |
Yaming Hang |
Proper way to handle the pre-first dose PK observation for non-endogenous drug
|
technical
|
| Nov 07, 2012 |
Matt Fidler |
RE: Proper way to handle the pre-first dose PK observation for non-endogenous drug
|
technical
|
| Nov 07, 2012 |
Nick Holford |
Re: RE: Proper way to handle the pre-first dose PK observation for non-endogenous drug
|
technical
|
| Nov 07, 2012 |
Daniel Tatosian |
Re: RE: Proper way to handle the pre-first dose PK observation for non-endogenous drug
|
technical
|
| Nov 08, 2012 |
Nick Holford |
Re: RE: Proper way to handle the pre-first dose PK observation for non-endogenous drug
|
technical
|
| Nov 08, 2012 |
Mats Karlsson |
RE: RE: Proper way to handle the pre-first dose PK observation for non-endogenous drug
|
technical
|
| Nov 08, 2012 |
Matt Fidler |
RE: RE: Proper way to handle the pre-first dose PK observation for non-endogenous drug
|
technical
|
| Nov 08, 2012 |
Yaming Hang |
RE: RE: Proper way to handle the pre-first dose PK observation for non-endogenous drug
|
technical
|
| Nov 08, 2012 |
Matt Hutmacher |
RE: RE: Proper way to handle the pre-first dose PK observation for non-endogenous drug
|
technical
|
| Nov 08, 2012 |
Kenneth Kowalski |
RE: RE: Proper way to handle the pre-first dose PK observation for non-endogenous drug
|
technical
|
| Nov 07, 2012 |
Matt Fidler |
RE: Proper way to handle the pre-first dose PK observation for
non-endogenous drug
|
technical
|
| Nov 07, 2012 |
Joel Tarning |
Oxford modelling vacancy
|
job
|
| Nov 05, 2012 |
Benjamin Ribba |
Postdoc position at INRIA, France - Modeling brain tumor
|
job
|
| Nov 05, 2012 |
Nicolas Frey |
Several open pharmacometrician positions at F. Hoffmann-La Roche Ltd (Switzerland, UK and US East-Coast)
|
job
|
| Nov 05, 2012 |
Nicolas Frey |
Several open pharmacometrician positions at F. Hoffmann-La Roche
Ltd (Switzerland, UK and US East-Coast)
|
job
|
| Nov 05, 2012 |
Nicolas Frey |
Several open pharmacometrician positions at F. Hoffmann-La Roche Ltd (Switzerland, UK and US west-coast)
|
job
|
| Nov 05, 2012 |
Nicolas Frey |
Several open pharmacometrician positions at F. Hoffmann-La Roche
Ltd (Switzerland, UK and US west-coast)
|
job
|